Vor BiopharmaVOR
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 36 institutions reported holding Vor Biopharma Inc. (VOR) in their 13F filings, up 35 from Q2 2025. 12 opened new positions and 1 sold out. The largest holders were Ra Capital Management, L.P. ($96.6M), Venrock Adviser, LLC ($24.4M) and FCPM III Services B.V. ($18.5M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Vor Biopharma Inc.
- CUSIP
- 929033207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $55.1M |
| Exits | 1 | $90K |
All 13F filers, Q2 2025 → Q3 2025: 1,317,802 shares bought and 94,737 shares sold, net +1,223,065 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 36 holders
| Ra Capital Management, L.P. | 1.19% | No change | 1,982,301 | $96.6M |
| Venrock Adviser, LLC | 1.37% | New | 499,966 | $24.4M |
| FCPM III Services B.V. | 3.70% | New | 379,640 | $18.5M |
| FMR LLC | 0.00% | Add +126.0% | 236,508 | $11.5M |
| Ariose Capital Management Ltd | 1.80% | New | 110,173 | $5.4M |
| Vanguard Group Inc. | 0.00% | Add +9.8% | 105,190 | $5.1M |
| UBS Group AG | 0.00% | Reduce -0.9% | 75,909 | $3.7M |
| Tang Capital Management LLC | 0.09% | New | 50,000 | $2.4M |
| BlackRock, Inc. | 0.00% | Add +84.3% | 34,530 | $1.7M |
| Geode Capital Management, LLC | 0.00% | Add +25.8% | 27,392 | $1.3M |
| Woodline Partners LP | 0.01% | New | 27,363 | $1.3M |
| Sarissa Capital Management LP | 0.69% | No change | 25,399 | $1.2M |
| Millennium Management | 0.00% | New | 24,764 | $1.2M |
| Polymer Capital Management (HK) LTD | 0.14% | New | 21,248 | $1.0M |
| Jane Street Group, LLC | 0.00% | Reduce -36.3% | 16,753 | $816K |
| Goldman Sachs Group Inc. | 0.00% | Add +74.6% | 15,786 | $769K |
| Renaissance Technologies | 0.00% | Reduce -37.6% | 14,600 | $711K |
| State Street Corp. | 0.00% | Add +56.2% | 9,054 | $441K |
| Virtu Financial LLC | 0.02% | Reduce -41.3% | 8,104 | $395K |
| Bridgeway Capital Management, LLC | 0.01% | New | 6,250 | $305K |
| Scientech Research LLC | 0.10% | Reduce -69.8% | 6,097 | $297K |
| BNP Paribas Financial Markets | 0.00% | Add +11846.9% | 6,075 | $296K |
| Citadel Advisors | 0.00% | New | 5,686 | $277K |
| Bank of America Corp. | 0.00% | Add +15486.9% | 4,754 | $232K |
| Squarepoint Ops LLC | 0.00% | New | 4,729 | $230K |
| Trustees of Columbia University in the City of New York | 0.03% | No change | 4,595 | $224K |
| Morgan Stanley | 0.00% | Add +17617.7% | 4,456 | $217K |
| Bollard Group LLC | 0.00% | No change | 2,777 | $135K |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 110 | $5K |
| JPMorgan Chase & Co. | 0.00% | Reduce -82.7% | 78 | $4K |
| MAI Capital Management | 0.00% | Reduce -78.1% | 40 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -96.5% | 4 | $195 |
| Allworth Financial LP | 0.00% | No change | 3 | $147 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -85.0% | 3 | $146 |
| Wells Fargo & Company | 0.00% | New | 1 | $49 |
| Royal Bank of Canada | 0.00% | Reduce -32.2% | 2 | $0 |
"% of holder's portfolio" is VOR's weight in each manager's 13F, not the share of Vor Biopharma Inc. the manager owns.